FPW
IBB icon

Fairvoy Private Wealth’s iShares Biotechnology ETF IBB Stock Holding History

Fairvoy Private Wealth’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$804K Sell
4,226
-5,739
-58% -$986K 0.16% 116
2026
Q1 		$1.68M Buy
+9,965
New +$1.7M 0.4% 62

Other funds holding IBB

GIC
Generali Investments CEE Prague, Czech Republic $2.11B AUM 25.53% 1-Year Est. Return
IHL
Investment House LLC Redondo Beach, California $1.92B AUM 25.81% 1-Year Est. Return
AP
Appleton Partners Boston, Massachusetts $1.63B AUM 38.57% 1-Year Est. Return
FMI
Factory Mutual Insurance Waltham, Massachusetts $10.6B AUM 34.1% 1-Year Est. Return
CA
Cumberland Advisors Sarasota, Florida $284M AUM 27.11% 1-Year Est. Return
FNFDCM
Folger Nolan Fleming Douglas Capital Management Washington, District of Columbia $1.22B AUM 34.81% 1-Year Est. Return
AC
Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return
RFA
Reyes Financial Architecture San Diego, California $179M AUM 31.17% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

Fairvoy Private Wealth's IBB Position: Q2 2026 in Review

Fairvoy Private Wealth reduced its iShares Biotechnology ETF (IBB) stake by 58% in Q2 2026, selling an estimated $986K and leaving 4,226 shares worth $804K. The position accounts for 0.16% of the portfolio, ranked #116.

Fairvoy Private Wealth first reported a position in IBB in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.68M in Q1 2026. 201 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Fairvoy Private Wealth held 4,226 shares of iShares Biotechnology ETF worth $804K as of Q2 2026.
  • Fairvoy Private Wealth sold 5,739 iShares Biotechnology ETF shares in Q2 2026, an estimated $986K.
  • iShares Biotechnology ETF made up 0.16% of Fairvoy Private Wealth's portfolio in Q2 2026, its #116 holding.
  • Fairvoy Private Wealth first reported a position in iShares Biotechnology ETF in Q1 2026 and has held it in 2 quarters since.
  • Fairvoy Private Wealth's iShares Biotechnology ETF position peaked at $1.68M in Q1 2026.
  • 201 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Fairvoy Private Wealth's 13F filing for Q2 2026, filed 17 Jul 2026.